4.8 Article

Monocyte-Derived Dendritic Cells Dictate the Memory Differentiation of CD8+ T Cells During Acute Infection

Journal

FRONTIERS IN IMMUNOLOGY
Volume 10, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2019.01887

Keywords

monocyte-derived dendritic cells; memory CD8(+) T cells; IFN-gamma; LCMV; acute infection

Categories

Funding

  1. Basic Science Research Program [NRF-2018R1A2A1A05077627]
  2. Bio & Medical Technology Development Program through the National Research Foundation of Korea - Ministry of Science ICT [NRF-2016M3A9B5941426]
  3. National Research Foundation of Korea [2016M3A9B5941426] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

Monocyte-derived dendritic cells (moDCs) have been shown to robustly expand during infection; however; their roles in anti-infectious immunity remain unclear. Here, we found that moDCs were dramatically increased in the secondary lymphoid organs during acute LCMV infection in an interferon-gamma (IFN-gamma)-dependent manner. We also found that priming by moDCs enhanced the differentiation of memory CD8(+) T cells compared to differentiation primed by conventional dendritic cells (cDCs) through upregulation of Eomesodermin (Eomes) and T cell factor-1 (TCF-1) expression in CD8(+) T cells. Consequently, impaired memory formation of CD8(+) T cells in mice that had reduced numbers of moDCs led to defective clearance of pathogens upon rechallenge. Mechanistically, attenuated interleukin-2 (IL-2) signaling in CD8(+) T cells primed by moDCs was responsible for the enhanced memory programming of CD8(+) T cells. Therefore, our findings unveil a specialization of the antigen-presenting cell subsets in the fate determination of CD8(+) T cells during infection and pave the way for the development of a novel therapeutic intervention on infection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

GITR Agonism Triggers Antitumor Immune Responses through IL21-Expressing Follicular Helper T Cells

Choong-Hyun Koh, Il-Kyu Kim, Kwang-Soo Shin, Insu Jeon, Boyeong Song, Jeong-Mi Lee, Eun-Ah Bae, Hyungseok Seo, Tae-Seung Kang, Byung-Seok Kim, Yeonseok Chung, Chang-Yuil Kang

CANCER IMMUNOLOGY RESEARCH (2020)

Article Oncology

PTHrP Drives Pancreatic Cancer Growth and Metastasis and Reveals a New Therapeutic Vulnerability

Jason R. Pitarresi, Robert J. Norgard, Anna M. Chiarella, Kensuke Suzuki, Basil Bakir, Varun Sahu, Jinyang Li, Jun Zhao, Benoit Marchand, Maximilian D. Wengyn, Antony Hsieh, Il-Kyu Kim, Amy Zhang, Karine Sellin, Vivian Lee, Shigetsugu Takano, Yoji Miyahara, Masayuki Ohtsuka, Anirban Maitra, Faiyaz Notta, Richard Kremer, Ben Z. Stanger, Anil K. Rustgi

Summary: The amplification of PTHrP in pancreatic cancer is related to tumor growth and metastasis, and its loss can significantly reduce tumor burden, eliminate metastasis, and enhance overall survival. Targeting PTHrP activity may be a novel therapeutic approach for treating pancreatic cancer.

CANCER DISCOVERY (2021)

Article Immunology

15-Deoxy-Δ12,14-Prostaglandin J2 Promotes Resolution of Experimentally Induced Colitis

Wonki Kim, Jeong-Hoon Jang, Xiancai Zhong, Hyungseok Seo, Young-Joon Surh

Summary: 15d-PGJ(2) promotes the resolution of intestinal colitis by reducing neutrophils and M1 macrophages, increasing M2 macrophage proportion, and decreasing the expression of pro-inflammatory cytokine IL-6 in macrophages.

FRONTIERS IN IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Calcium signaling induces a partial EMT

Robert J. Norgard, Jason R. Pitarresi, Ravikanth Maddipati, Nicole M. Aiello-Couzo, David Balli, Jinyang Li, Taiji Yamazoe, Maximilian D. Wengyn, Ian D. Millstein, Ian W. Folkert, Derick N. Rosario-Berrios, Il-Kyu Kim, Jared B. Bassett, Riley Payne, Corbett T. Berry, Xiaodong Feng, Kathryn Sun, Michele Cioffi, Priyanka Chakraborty, Mohit Kumar Jolly, J. Silvio Gutkind, David Lyden, Bruce D. Freedman, J. Kevin Foskett, Anil K. Rustgi, Ben Z. Stanger

Summary: Epithelial-mesenchymal transition (EMT) is a form of cellular plasticity that gives tumor cells invasiveness and alters their sensitivity to drugs, posing a challenge to cancer therapy. Carcinoma cells in a partial EMT state have higher metastatic capacity than those in extreme states. Prolonged calcium signaling induces a partial EMT characterized by the internalization of membrane-associated E-cadherin and increased migration and invasion abilities.

EMBO REPORTS (2021)

Article Immunology

BATF and IRF4 cooperate to counter exhaustion in tumor-infiltrating CAR T cells

Hyungseok Seo, Edahi Gonzalez-Avalos, Wade Zhang, Payal Ramchandani, Chao Yang, Chan-Wang J. Lio, Anjana Rao, Patrick G. Hogan

Summary: BATF and IRF4 cooperate to counter T cell exhaustion in mouse tumor models, promoting better tumor control by CAR T cells.

NATURE IMMUNOLOGY (2021)

Article Immunology

MicroRNA-139 Expression Is Dispensable for the Generation of Influenza-Specific CD8+ T Cell Responses

Jennifer L. Hope, Manzhi Zhao, Christopher J. Stairiker, Caoimhe H. Kiernan, Alison J. Carey, Yvonne M. Mueller, Marjan van Meurs, Inge Brouwers-Haspels, Dennis C. Otero, Eun-Ah Bae, Hannah A. Faso, Alex Maas, Hans de Looper, Paolo M. Fortina, Isidore Rigoutsos, Linda M. Bradley, Stefan J. Erkeland, Peter D. Katsikis

Summary: This study characterized the expression profile of miRNAs in antiviral CD8(+) T cells and found that miR-139 was highly downregulated in effector CTLs. However, the deficiency or overexpression of miR-139 did not affect the development and response of immune cells.

JOURNAL OF IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

Dysregulation of TFH-B-TRM lymphocyte cooperation is associated with unfavorable anti-PD-1 responses in EGFR-mutant lung cancer

Jae-Won Cho, Seyeon Park, Gamin Kim, Heonjong Han, Hyo Sup Shim, Sunhye Shin, Yong-Soo Bae, Seong Yong Park, Sang-Jun Ha, Insuk Lee, Hye Ryun Kim

Summary: This study found that B cells, CXCL13-producing follicular helper CD4(+) T (T-FH)-like cells, and tissue-resident memory CD8(+) T (T-RM)-like cells decreased in EGFR mutant tumors. The proportion of T-RM-like cells is predictive for anti-PD-1 response in NSCLC.

NATURE COMMUNICATIONS (2021)

Article Oncology

Induction of the activating transcription factor-4 in the intratumoral CD8+T cells sustains their viability and anti-tumor activities

Zhen Lu, Eun-Ah Bae, Ioannis I. Verginadis, Hongru Zhang, Christina Cho, Noreen McBrearty, Subin S. George, J. Alan Diehl, Constantinos Koumenis, Linda M. Bradley, Serge Y. Fuchs

Summary: The immune suppressive factors in the tumor microenvironment can weaken the viability and activities of CD8 + T cells, and activating transcription factor-4 (ATF4) plays an important role in maintaining the survival and activities of CD8 + T cells in the tumor microenvironment.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2023)

Article Oncology

Effi cacy of a Small-Molecule Inhibitor of Kras G12D in Immunocompetent Models of Pancreatic Cancer

Samantha B. Kemp, Noah Cheng, Nune Markosyan, Rina Sor, Il-Kyu Kim, Jill Hallin, Jason Shoush, Liz Quinones, Natalie V. Brown, Jared B. Bassett, Nikhil Joshi, Salina Yuan, Molly Smith, William P. Vostrejs, Kia Z. Perez-Vale, Benjamin Kahn, Feiyan Mo, Timothy R. Donahue, Caius G. Radu, Cynthia Clendenin, James G. Christensen, Robert H. Vanderheide, Ben Z. Stanger

Summary: This study evaluated the efficacy of a small-molecule KRASG12D inhibitor, MRTX1133, in PDAC models with an intact immune system. The results showed that MRTX1133 can induce deep tumor regressions and alter the tumor microenvironment, demonstrating its potential as a novel therapy for PDAC patients. Further clinical testing is warranted.

CANCER DISCOVERY (2023)

Article Cell Biology

PSGL-1 attenuates early TCR signaling to suppress CD8+T cell progenitor differentiation and elicit terminal CD8+T cell exhaustion

Jennifer L. Hope, Dennis C. Otero, Eun-Ah Bae, Christopher J. Stairiker, Ashley B. Palete, Hannah A. Faso, Michelle Lin, Monique L. Henriquez, Sreeja Roy, Hyungseok Seo, Xue Lei, Eric S. Wang, Savio Chow, Roberto Tinoco, Gregory A. Daniels, Kevin Yip, Alexandre Rosa Campos, Jun Yin, Peter D. Adams, Anjana Rao, Linda M. Bradley

Summary: PSGL-1 is a T cell-intrinsic checkpoint regulator that acts upstream of PD-1 and requires co-ligation with the TCR to attenuate T cell activation and drive terminal T cell exhaustion. PSGL-1 directly restrains TCR signaling via Zap70 and maintains expression of the Zap70 inhibitor Sts-1. Deficiency of PSGL-1 empowers CD8+ T cells to respond to low-affinity TCR ligands and inhibit the growth of PD-1-blockade-resistant melanoma.

CELL REPORTS (2023)

Article Immunology

Better understanding CD8+ T cells in cancer and viral infections

Hoyoung Lee, Min Kyung Jung, Ji Yun Noh, Su-Hyung Park, Yeonseok Chung, Sang-Jun Ha, Eui-Cheol Shin

Summary: The first conference on 'Infection and Immunity' focused on the biology of CD8+ T cells in the context of viral disease and cancer.

NATURE IMMUNOLOGY (2023)

Meeting Abstract Immunology

BATF and IRF4 cooperate to counter exhaustion in tumour-infiltrating CART cells

Hyungseok Seo, Edahi Gonzales-Avalos, Wade Zhang, Chan Lio, Anjana Rao, Patrick Hogan

JOURNAL OF IMMUNOLOGY (2021)

Article Oncology

Epigenetic and Transcriptional Control of the Epidermal Growth Factor Receptor Regulates the Tumor Immune Microenvironment in Pancreatic Cancer

Jinyang Li, Salina Yuan, Robert J. Norgard, Fangxue Yan, Yu H. Sun, Il-Kyu Kim, Allyson J. Merrell, Yogev Sela, Yanqing Jiang, Natarajan Bhanu, Benjamin A. Garcia, Robert H. Vonderheide, Andres Blanco, Ben Z. Stanger

Summary: This study identifies lysine demethylase 3A (KDM3A) as an epigenetic regulator that affects the response to immunotherapy in pancreatic ductal adenocarcinoma by modulating the expression of epidermal growth factor receptor (EGFR) through Krueppel-like factor 5 (KLF5) and SMAD family member 4 (SMAD4). Inhibition of EGFR can reshape the immune microenvironment, offering a potential immunotherapy-sensitizing strategy for PDA.

CANCER DISCOVERY (2021)

No Data Available